Artificial expression of TP53 induces erythroid differentiation in chronic myelogenous leukemia cells; it also induces cell-cycle arrest and anemia in disorders such as Diamond-Blackfan anemia and the 5q- syndrome [36, 37]. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.